Skip to main content
. Author manuscript; available in PMC: 2022 Jul 5.
Published in final edited form as: Eur J Med Chem. 2021 Apr 10;219:113446. doi: 10.1016/j.ejmech.2021.113446

Table 4.

The structures of ATAD2

PDB Code Methods (Å) Macromolecules Ligands Organisms References
3DAI X-ray (2.0) SM+Q981-R1108 - hsa [128]
4QSP X-ray (1.6) SM+Q981-R1108 N(6)-ACETYLLYSINE hsa [129]
4QSQ X-ray (1.8) SM+Q981-R1108 - hsa [129]
4QSR X-ray (2.0) SM+Q981-R1108 - hsa [129]
4QSS X-ray (2.0) SM+Q981-R1108 - hsa [129]
4QST X-ray (2.1) SM+Q981-R1108 1-METHYLQUINOLIN-2(1H)-ONE hsa [129]
4QSU X-ray (1.9) SM+Q981-R1108 THYMINE hsa [129]
4QSV X-ray (1.9) SM+Q981-R1108 THYMIDINE hsa [129]
4QSW X-ray (1.8) SM+Q981-R1108 5-methyluridine hsa [129]
4QSX X-ray (1.9) SM+Q981-R1108 1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione hsa [129]
4QUT X-ray (1.7) SM+Q981-R1108 - hsa [130]
4QUU X-ray (1.8) SM+Q981-R1108 - hsa [130]
4TT2 X-ray (2.5) SM+Q981-R1108 - hsa [131]
4TT4 X-ray (2.7) SM+Q981-R1108 - hsa [131]
4TT6 X-ray (2.0) SM+Q981-R1108 - hsa [131]
4TTE X-ray (1.8) SM+Q981-R1108 methyl 3-amino-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzoate hsa [131]
4TU4 X-ray (1.7) SM+Q981-R1108 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[(phenylsulfonyl)amino]benzoic acid hsa [131]
4TU6 X-ray (2.3) SM+Q981-R1108 - hsa [131]
4TYL X-ray (1.9) SM+Q981-R1108 5-amino-1,3,6-trimethyl-1,3-dihydro-2H-benzimidazol-2-one hsa [124]
4TZ2 X-ray (1.7) SM+Q981-R1108 3-(5-phenyl-4H-1,2,4-triazol-3-yl)aniline hsa [124]
4TZ8 X-ray (2.2) SM+Q981-R1108 2-amino-7,7-dimethyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[5,4-c]azepin-4-one hsa [124]
5A5N X-ray (2.0) SM+Q981-R1108 (2S)-2,6-diacetamido-N-methyl-hexanamide hsa [125]
5A5O X-ray (2.0) SM+Q981-R1108 3-METHYL-1,2-DIHYDROQUIN OLIN-2-ONE hsa [125]
5A5P X-ray (2.0) SM+Q981-R1108 8-[2-(dimethylamino)ethylamino]-3-methyl-1,2-dihydroquinolin-2-one hsa [125]
5A5Q X-ray (2.0) SM+Q981-R1108 3-methyl-8-[(piperidin-4-yl)amino]-1,2-dihydro-1,7-naphthyridin-2-one hsa [125]
5A5R X-ray (2.0) SM+Q981-R1108 5-(5-methoxypyridin-3-yl)-3-methyl-8-[(piperidin-4-yl)amino]-1,2-dihydro-1,7-naphthyridin-2-one hsa [125]
5A81 X-ray (2.0) SM+Q981-R1108 (3R,4R)-3-(cyclohexylmethoxy)piperidin-4-yl]amino}-3-methyl-1,2-dihydro-1,7-naphthyridin-2-one hsa [126]
5A82 X-ray (1.9) SM+Q981-R1108 8-[[(3R,4R)-3-[[1,1-bis(oxidanylidene)thian-4-yl]methoxy]piperidin-4-yl]amino]-3-methyl-1H-1,7-naphthyridin-2-one hsa [126]
5A83 X-ray (2.1) SM+Q981-R1108 8-[[(3R,4R)-3-[[1,1-bis(oxidanylidene)thian-4-yl]methoxy]piperidin-4-yl]amino]-3-methyl-5-(5-methylpyridin-3-yl)-1H-quinolin-2-one hsa [126]
5LJ0 X-ray (1.8) SM+Q981-R1108 8-(((3R,4R,5S)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one hsa [127]
6CPS X-ray (1.9) GPL+Q981-R1108 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID hsa [132]
6HDN X-ray (1.9) SM+Q981-R1108 3-methyl-8-((8-methyl-8-azabicyclooctan-3-yl)amino)-1,7-naphthyridin-2(1H)-one hsa [133]
6HDO X-ray (2.6) SM+Q981-R1108 8-(((1R,2R,3R,5S)-2-(2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)quinolin-2(1H)-one hsa [133]
6S55 X-ray (2.1) SM+Q981-R1108 N-(4-bromo-3-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-2-(2,5-dioxoimidazolidin-1-yl)acetamide hsa [134]
6S56 X-ray (2.0) SM+Q981-R1108 N-(4-chloro-3-(N,N-dimethylsulfamoyl)phenyl)-2-(2,5-dioxo-3′,4′-dihydro-2′H-spiro[imidazolidine-4,1′-naphthalen]-1-yl)acetamide hsa [134]
6S57 X-ray (1.8) SM+Q981-R1108 N-(3-(azepan-1-ylsulfonyl)-4-methylphenyl)-2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)acetamide hsa [134]
6YB4 X-ray (1.9) SM+Q981-R1108 N-(4-bromo-3-(3-methylpyrrolidin-1-yl)sulfonyl)phenyl)-2-(-4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetamide hsa [135]

hsa: Homo sapiens; -: no ligands. PDB Accessed on June 3, 2020.